Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Polymorphic Post-Transplant Lymphoproliferative Disorder

Known as: Polymorphic B-Cell Lymphoma, Polymorphic PTLD 
A clonal B-cell lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterized by destructive… Expand
National Institutes of Health

Related topics

Related topics

16 relations
Atypical lymphocyteB lymphoblastB-LymphocytesEpstein-Barr Virus Infections
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Mutational landscape of B‐cell post‐transplant lymphoproliferative disorders
It is currently unclear whether post-transplant diffuse large B-cell lymphomas (PT-DLBCL) display a similar genomic landscape as… Expand
  • figure 1
  • figure 2
Is this relevant?
2017
2017
Epstein-Barr virus-positive mucocutaneous ulcer arising in a post-hematopoietic cell transplant patient followed by polymorphic posttransplant lymphoproliferative disorder and cytomegalovirus colitis…
Epstein-Barr virus (EBV)-positive mucocutaneous ulcer (EBVMCU) is a newly described entity occurring in elderly or iatrogenically… Expand
Is this relevant?
2015
2015
Post-transplant lymphoproliferative disorders with naso- and oropharyngeal manifestation.
The nasopharyngeal/oropharyngeal lymphatic tissues represent the anatomical site of Epstein-Barr virus (EBV) entry. Post… Expand
Is this relevant?
Review
2009
Review
2009
Pediatric post-transplant lymphoproliferative disorder after cardiac transplantation
Post-transplant lymphoproliferative disorder (PTLD) is a well recognized and potentially fatal complication after pediatric… Expand
Is this relevant?
2009
2009
Post-Transplant Lymphoproliferative Disorders: Role of Viral Infection, Genetic Lesions and Antigen Stimulation in the Pathogenesis of the Disease
Post-transplant lymphoproliferative disorders (PTLD) are a life-threatening complication of solid organ transplantation or, more… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.
BACKGROUND Single-agent rituximab has demonstrated encouraging efficacy and tolerability in posttransplant lymphoproliferative… Expand
  • figure 1
  • figure 2
Is this relevant?
Review
2006
Review
2006
Post-transplant lymphoproliferative disorders.
Post-transplant lymphoproliferative disorder is the most common malignancy, with the exception of skin cancer, after solid organ… Expand
  • table 1
  • figure 1
Is this relevant?
2005
2005
PTLD visualization by FDG-PET: improved detection of extranodal localizations.
Posttransplant lymphoproliferative disease (PTLD) is a serious complication that may arise after solid organ transplantation… Expand
Is this relevant?
Review
2004
Review
2004
Post-transplant plasma cell myeloma and polymorphic lymphoproliferative disorder with monoclonal serum protein occurring in solid organ transplant recipients
Post-transplant lymphoproliferative disorders are mostly Epstein–Barr virus-related, B-cell tumors that develop as a consequence… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
2004
2004
Flow cytometric evaluation of posttransplant B-cell lymphoproliferative disorders.
CONTEXT Posttransplant B-cell lymphoproliferative disorders (PTLDs) constitute a heterogeneous group that includes hyperplastic… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE